KLRK1 and neoplasm: To explore if the release of sNKG2DL by leukemic cells could be hindering the anti-tumor ability of NKG2D-CAR T cells in the murine model, we measured the levels of sNKG2DL and their impact on NKG2D-CAR T cells.